Amneal Pharmaceuticals will report its second quarter 2026 financial results on July 30, 2026, before market open. The announcement will provide insights into the company's performance for the quarter, with a live audio webcast scheduled for 8:30 a.m. ET to discuss the details. Investors and stakeholders can access the financial results and the live webcast through the Investor Relations section of Amneal's website at investors.amneal.com.

Access Details

To participate in the webcast, individuals must register in advance through the provided link on the company's website. For those preferring to join via phone, domestic participants in the U.S. can dial 1 (833) 461-5787, while international callers can access a list of toll-free numbers on the site. The access code required for the call is 901153095. A replay of the webcast will be made available shortly after the conclusion of the live event.

About Amneal Pharmaceuticals

Amneal Pharmaceuticals is a global biopharmaceutical company headquartered in Bridgewater, New Jersey. Founded in 2002 by co-CEOs Chirag and Chintu Patel, the company focuses on expanding access to affordable and innovative medicines. Its portfolio includes approximately 300 complex, specialty, and biosimilar medicines, with over 160 million prescriptions delivered annually, primarily in the United States. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE, catering to diverse healthcare needs.